4Viswanathan V, Jasmine JJ, Snehalatha C. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients [J]. J Assoc Physicians India, 2002,50:1013-1016.
5Landman D,Quale J.Pseudomonas aeruginosa and Acinetobacter baumannii:pathogens of the millennium[J].Ochsner Clinic Reports on Serious Hospital Infection,2002,14(1):1-7.
6Giamarellos-Bourboulis EJ,Papadimitriou E,Galanakis N,et al.Multidrug resistance to anti_microbials as a predmominant factor influencing patient survival[J].Int J Antimicrob Agents,2006,27(3):476-481.
7Livemore DM.Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:our worst nightmare[J]? Anntimicrobial Resistance,2002,34(5):634-640.
8Yagupsky P.Selection of antibiotic-resis-tant pathogens in the community[J].Pediatr Infect Dis J,2006,48(8):161-176.
9Oudhuis GJ,Verbon A,Hoogkamp-Korstanje JA,et al.Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands,1998-2005[J].Int J Antimicrob Agents,2008,31(3):58-63.
10Paramythiotou E,Lucet JC,Timsit JF,et al.Acquisition ofmultidrug-resistantPseudomonas aeruginosain patients in intensive care units:role of antibiotics with antipseudomonal activity[J].Clin Infect Dis,2004,38(2):670-677.
